The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine

This publication has 60 references indexed in Scilit:

• Interleukin-6 has differential influence on the ability of adjuvant formulations to potentiate antibody reponses to a Plasmodium falciparum blood-stage vaccine
  Vaccine, 2007
• Immunity to RecombinantPlasmodium falciparumMerozoite Surface Protein 1 (MSP1): Protection inAotus nancymaiMonkeys Strongly Correlates with Anti-MSP1 Antibody Titer and In Vitro Parasite-Inhibitory Activity
  Infection and Immunity, 2006
• Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
  Proceedings of the National Academy of Sciences, 2006
• Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands
  Cellular and Molecular Life Sciences, 2006
• THE B7 FAMILY REVISITED
  Annual Review of Immunology, 2005
• CD8+ T-cell priming regulated by cytokines of the innate immune system
  Trends in Molecular Medicine, 2004
• Molecular characterization of dendritic cells operating at the interface of innate of acquired immunity
  Pathologie Biologie, 2003
• Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720
  Vaccine, 1997
• Accessory Molecule and Costimulation Requirements for CD4 T Cell Response
  Critical Reviews in Immunology, 1997
• T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles
  Critical Reviews in Immunology, 1995